masoprocol has been researched along with Pancreatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dizdar, L; Esposito, I; Knoefel, WT; Krieg, A; Mersch, S; Möhlendick, B; Oesterwind, KA; Raba, K; Riemer, JC; Schütte, SC; Stoecklein, NH; Topp, SA; Verde, PE; Werner, TA | 1 |
| Adrian, TE; Ding, XZ; El-Metwally, TH; Kuszynski, CA | 1 |
| Adler, G; Baust, H; Beil, M; Lührs, H; Schmid, RM; Schwarz, E; Seckl, MJ; Seufferlein, T; v Wichert, G | 1 |
3 other study(ies) available for masoprocol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Comparative Genomic Hybridization; DNA Copy Number Variations; Dose-Response Relationship, Drug; Female; Gene Dosage; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Intestinal Neoplasms; Male; Masoprocol; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Naphthoquinones; Oligonucleotide Array Sequence Analysis; Pancreatic Neoplasms; Retrospective Studies; RNA Interference; Signal Transduction; Stomach Neoplasms; Survivin; Time Factors; Transfection; Tumor Burden; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2017 |
Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells.
Topics: Apoptosis; Carbonic Anhydrases; Cell Differentiation; Cell Division; Cell Size; DNA Fragmentation; Flavanones; Flavonoids; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; In Situ Nick-End Labeling; Lipoxygenase Inhibitors; Masoprocol; Pancreatic Neoplasms; Propidium; Quinolines; Tumor Cells, Cultured | 1999 |
Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells.
Topics: Actins; Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Division; Cytoskeleton; Female; Humans; Lipoxygenase Inhibitors; Masoprocol; Mice; Pancreatic Neoplasms; Protein Kinases; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2002 |